Artiva Biotherapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Artiva Biotherapeutics, Inc. reported Earnings Per Share Diluted of $3.43 (loss) per share for the year ending 2025.

  • Artiva Biotherapeutics, Inc. showed an increase of +41.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Artiva Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Artiva Biotherapeutics, Inc.'s Earnings Per Share Diluted has grown by 90.4%.
  • Historical annual values: Fiscal year 2025: $3.43 (loss) per share | Fiscal year 2024: $5.81 (loss) per share | Fiscal year 2023: $35.78 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: